RTOG 0131: PHASE II TRIAL OF PRE-IRRADIATION AND CONCURRENT TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED ANAPLASTIC OLIGODENDROGLIOMAS AND MIXED ANAPLASTIC OLIGODENDROGLIOMAS: UPDATED SURVIVAL AND PROGRESSION FREE SURVIVAL ANALYSIS Conference

Vogelbaum, Michael A, Wang, Meihua, Peereboom, David M et al. (2012). RTOG 0131: PHASE II TRIAL OF PRE-IRRADIATION AND CONCURRENT TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED ANAPLASTIC OLIGODENDROGLIOMAS AND MIXED ANAPLASTIC OLIGODENDROGLIOMAS: UPDATED SURVIVAL AND PROGRESSION FREE SURVIVAL ANALYSIS . NEURO-ONCOLOGY, 14 75-76.

International Collaboration

cited authors

  • Vogelbaum, Michael A; Wang, Meihua; Peereboom, David M; Macdonald, David R; Giannini, Caterina; Suh, John H; Jenkins, Robert B; Laack, Nadia N; Brackman, David G; Shrieve, Dennis C; Souhami, Luis; Mehta, Minesh P

sustainable development goals

authors

date/time interval

  • November 15, 2012 -

publication date

  • October 1, 2012

webpage

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

Location

  • Washington, DC

Conference

  • 17th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 75

end page

  • 76

volume

  • 14